Therapeutic advances in immunosuppression
- 1 December 1994
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 98 (3) , 351-357
- https://doi.org/10.1111/j.1365-2249.1994.tb05496.x
Abstract
SUMMARY: Immunosuppressive therapy is appropriate for the prevention or reversal of allograft rejection, and for the treatment of autoimmune disorders and allergic disease. Recent advances in our understanding of the cellular and molecular mechanisms that regulate immune responses have paralleled elucidation of the modes of action of a variety of therapeutic immunosuppressive agents, both ‘old’ and new. These developments have identified potential targets for more refined and specific intervention strategies that are now being tested in the clinic.Keywords
This publication has 66 references indexed in Scilit:
- The mechanism of action of cyclosporin A and FK506Published by Elsevier ,2003
- Rapamycin: A novel immunosuppressive macrolideMedicinal Research Reviews, 1994
- Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor αArthritis & Rheumatism, 1993
- Anti-inflammatory actions of steroids: molecular mechanismsTrends in Pharmacological Sciences, 1993
- Saying the ‘S’ word in publicImmunology Today, 1993
- TacrolimusDrugs, 1993
- Analysis of human T cell responses to the group II allergen of Dermatophagoides species: Localization of major antigenic sitesJournal of Allergy and Clinical Immunology, 1993
- Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantationImmunology Today, 1993
- FK506 and cyclosporin, molecular probes for studying intracellular signal transductionImmunology Today, 1993
- THERAPEUTIC POTENTIAL OF MONOCLONAL ANTIBODIES TO THE LEUKOCYTE-COMMON ANTIGENTransplantation, 1985